临床特点 | 总计 (N = 105) | 高MDR1 (N = 53) | 低MDR1 (N = 52) | P | 高BAALC (N = 53) | 低BAALC (N = 52) | P |
年龄 | 38.0 ± 12.9 | 37.8 ± 12.6 | 38.1 ± 13.3 | 0.922 | 40.1 ± 12.7 | 35.8 ± 12.8 | 0.091 |
性别n (%) |
|
|
|
|
|
|
|
女性 | 52 (49.5) | 25 (47.2) | 27 (51.9) | 0.772 | 28 (52.8) | 24 (46.2) | 0.494 |
FAB分型 |
|
|
| 0.851 |
|
| 0.857 |
M1 | 3 | 2 | 1 |
| 2 | 1 |
|
M2 | 38 | 20 | 18 | 19 | 19 | ||
M4 | 12 | 7 | 5 | 7 | 5 | ||
M5 | 36 | 19 | 17 | 21 | 15 | ||
M6 | 2 | 0 | 2 | 1 | 1 | ||
MDS转化 | 6 | 3 | 3 | 2 | 4 | ||
未定型 | 8 | 4 | 4 | 3 | 5 | ||
WBC | 49.4 ± 68.9 | 58.5 ± 72.9 | 40.2 ± 63.8 | 0.175 | 42.7 ± 70.0 | 56.0 ± 67.7 | 0.326 |
骨髓原始细胞比例 | 62.6 ± 24.7 | 62.7 ± 25.1 | 62.5 ± 24.6 | 0.956 | 63.2 ± 26.9 | 62.0 ± 22.6 | 0.815 |